A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy
American Journal of Translational Research · 2026 · 18 (7) · 5688-5703
DOI: 10.62347/fykp7669 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Weiwei Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Binzhou People's Hospital Binzhou 256600, Shandong, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Binzhou People's Hospital Binzhou 256600, Shandong, China.
Zitieren
APA
Li, W., Wang, Z., & Xiao, Z. (2026). A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy. American Journal of Translational Research, 18(7), 5688-5703. https://doi.org/10.62347/fykp7669
Vancouver
Li W, Wang Z, Xiao Z. A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy. American Journal of Translational Research. 2026;18(7):5688-5703. doi:10.62347/fykp7669
BibTeX
@article{Li2026,
author = {Li, Weiwei and Wang, Zhongmin and Xiao, Zhi},
title = {A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5688--5703},
doi = {10.62347/fykp7669}
}
EUVIMED